Cargando…
Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3
The success of CD8(+) T cell-based cancer immunotherapy emphasizes the importance of understanding the mechanisms of generation of MHC-I peptide ligands and the possible pathways of tumor cell escape from immunosurveillance. Recently, we showed that peptides generated in the nucleus during a pioneer...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458623/ https://www.ncbi.nlm.nih.gov/pubmed/32923122 http://dx.doi.org/10.1080/2162402X.2020.1761205 |
_version_ | 1783576236603211776 |
---|---|
author | Boulpicante, Mathilde Darrigrand, Romain Pierson, Alison Salgues, Valérie Rouillon, Marine Gaudineau, Benoit Khaled, Mehdi Cattaneo, Angela Bachi, Angela Cascio, Paolo Apcher, Sébastien |
author_facet | Boulpicante, Mathilde Darrigrand, Romain Pierson, Alison Salgues, Valérie Rouillon, Marine Gaudineau, Benoit Khaled, Mehdi Cattaneo, Angela Bachi, Angela Cascio, Paolo Apcher, Sébastien |
author_sort | Boulpicante, Mathilde |
collection | PubMed |
description | The success of CD8(+) T cell-based cancer immunotherapy emphasizes the importance of understanding the mechanisms of generation of MHC-I peptide ligands and the possible pathways of tumor cell escape from immunosurveillance. Recently, we showed that peptides generated in the nucleus during a pioneer round of mRNA translation (pioneer translation products, or PTPs) are an important source of tumor specific peptides which correlates with the aberrant splicing and transcription events associated with oncogenesis. Here we show that up-regulation of PSME3 proteasome activator in cancer cells results in increased destruction of PTP-derived peptides in the nucleus thus enabling cancer cell to subvert immunosurveillance. These findings unveil a previously unexpected role for PSME3 in antigen processing and identify PSME3 as a druggable target to improve the efficacy of cancer immunotherapy. |
format | Online Article Text |
id | pubmed-7458623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-74586232020-09-11 Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 Boulpicante, Mathilde Darrigrand, Romain Pierson, Alison Salgues, Valérie Rouillon, Marine Gaudineau, Benoit Khaled, Mehdi Cattaneo, Angela Bachi, Angela Cascio, Paolo Apcher, Sébastien Oncoimmunology Original Research The success of CD8(+) T cell-based cancer immunotherapy emphasizes the importance of understanding the mechanisms of generation of MHC-I peptide ligands and the possible pathways of tumor cell escape from immunosurveillance. Recently, we showed that peptides generated in the nucleus during a pioneer round of mRNA translation (pioneer translation products, or PTPs) are an important source of tumor specific peptides which correlates with the aberrant splicing and transcription events associated with oncogenesis. Here we show that up-regulation of PSME3 proteasome activator in cancer cells results in increased destruction of PTP-derived peptides in the nucleus thus enabling cancer cell to subvert immunosurveillance. These findings unveil a previously unexpected role for PSME3 in antigen processing and identify PSME3 as a druggable target to improve the efficacy of cancer immunotherapy. Taylor & Francis 2020-05-21 /pmc/articles/PMC7458623/ /pubmed/32923122 http://dx.doi.org/10.1080/2162402X.2020.1761205 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Boulpicante, Mathilde Darrigrand, Romain Pierson, Alison Salgues, Valérie Rouillon, Marine Gaudineau, Benoit Khaled, Mehdi Cattaneo, Angela Bachi, Angela Cascio, Paolo Apcher, Sébastien Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 |
title | Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 |
title_full | Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 |
title_fullStr | Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 |
title_full_unstemmed | Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 |
title_short | Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3 |
title_sort | tumors escape immunosurveillance by overexpressing the proteasome activator psme3 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458623/ https://www.ncbi.nlm.nih.gov/pubmed/32923122 http://dx.doi.org/10.1080/2162402X.2020.1761205 |
work_keys_str_mv | AT boulpicantemathilde tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT darrigrandromain tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT piersonalison tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT salguesvalerie tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT rouillonmarine tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT gaudineaubenoit tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT khaledmehdi tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT cattaneoangela tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT bachiangela tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT casciopaolo tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 AT apchersebastien tumorsescapeimmunosurveillancebyoverexpressingtheproteasomeactivatorpsme3 |